Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

22.96

+1.19 (5.47%)

At close: Jul 14, 2025, 4:00 PM

23.07

+0.11 (0.48%)

After-hours: Jul 14, 2025, 5:24 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biologic Therapeutics	1.80M	Log In
Biologic Therapeutics Growth	-17.88%	Log In

Revenue by Geography

Fiscal year is January - December.